secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001437749-26-013646
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health amends exec stock awards, eliminates repurchase right; expects $9.4M Q2 expense
--------------------------------------------------------------------------------

- Committee amended grants to CEO Trent Green (500k shares), COO Helen Hrdy (100k), and Chief Corp Dev Officer Andrew Monich (100k) to eliminate repurchase right.
- Cash bonuses approved: ~$1.9M for Green, ~$0.5M each for Hrdy and Monich to cover estimated taxes from award changes.
- Expected Q2 2026 expense of $9.4M: ~$6.5M non-cash accelerated equity comp and ~$2.9M cash bonus expense.
- Effective tax rate impacted by non-deductibility of amounts; future period charges eliminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774926013646/0001437749-26-013646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774926013646/nrc20260425_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-013646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer